Back to homepage

Tag "pharmacoeconomics"

Overcoming hurdles: measurement of health-related outcomes associated with national level medicines usage in Ireland

Authors: Gary L O’Brien BPharm, MPharm, Muireann McAlister BSc Pharmacy, Stephen Byrne BSc Pharmacy, PhD, James Gallagher BPharm, MPharm, PhD

This editorial provides an overview of the evolving healthcare landscape surrounding medicine usage estimation and valuation in Ireland and offers recommendations on how improved methods of measuring health-related outcomes may help ameliorate efficiencies and the sustainability of a healthcare system.


Considerations for the US health-system pharmacist in a world of biosimilars

Authors: Andrea Zlatkus CRHC, Todd Bixby RPh, Kavitha Goyal MD

This editorial article provides an overview of the evolving healthcare landscape shaped by the entry of multiple biosimilars, including for a given reference product, and their impact on the healthsystem pharmacist with respect to formulary assessment, implementation, and education of various health-system stakeholders, including patients.